Invest Northern Ireland

Fundmypitch is a platform that bridges the gap between angel investors and businesses seeking investment. They provide a transparent and ultra-secure environment for investors and entrepreneurs to interact and connect.

Neurovalens Limited specializes in the development of non-invasive neurostimulation medical devices aimed at addressing global health challenges such as obesity. Founded in 2013 and headquartered in Ballymena, United Kingdom, the company offers products like Stimu Slim and Modius, which are electronic headsets designed to influence brain activity and support weight management. Neurovalens employs advanced technologies to activate specific brain regions, enabling adjustments in autonomic function and neuro-metabolic processes. The company has received funding from Invest NI as part of the European Union’s Investment for Growth and Jobs Programme to support its research and development initiatives, enhancing its competitiveness in the field of neuroscience and bioscience.

GoPlugable is a pioneering startup that connects electric vehicle (EV) drivers with private, slow-charging points in homes and businesses via a user-friendly mobile app. The company's peer-to-peer platform enables EV drivers without access to home charging to book and pay for charging sessions, while hosts can monetize their idle chargers and businesses can enhance customer experience and sustainability efforts. With a focus on slow charging, GoPlugable differentiates itself from major providers and has secured strategic partnerships with brands like Ohme and SSE Airtricity. As of 2024, the platform has over 1,200 downloads and has achieved notable growth with 120 host users and 450 chargee users, demonstrating its potential in the expanding EV charging market.

CV6 Therapeutics is a drug development company dedicated to discovering and commercializing innovative therapies for human diseases, with a particular emphasis on cancer treatment. The company specializes in analyzing cancer cells to identify new drug targets, focusing on exploiting vulnerabilities within these cells. This approach aims to address challenges such as chemotherapy resistance, enabling the development of effective therapeutics. By supporting researchers and medical professionals, CV6 Therapeutics seeks to enhance treatment options and improve the quality of life for patients suffering from cancer and inflammatory diseases.

CV6 Therapeutics is a drug development company dedicated to discovering and commercializing innovative therapies for human diseases, with a particular emphasis on cancer treatment. The company specializes in analyzing cancer cells to identify new drug targets, focusing on exploiting vulnerabilities within these cells. This approach aims to address challenges such as chemotherapy resistance, enabling the development of effective therapeutics. By supporting researchers and medical professionals, CV6 Therapeutics seeks to enhance treatment options and improve the quality of life for patients suffering from cancer and inflammatory diseases.

TruCorp specializes in the design, engineering, and production of training manikins for airway management and other medical training needs. Their product range includes manikins for adult and pediatric CPR, AED training, trauma training, and various procedural skills. TruCorp aims to enhance medical education by providing anatomically accurate simulators that improve the training of healthcare professionals. By focusing on continuous innovation and refinement, the company seeks to advance medical skill training and ultimately enhance patient safety in various clinical settings.

Signum Surgical Limited, founded in 2014 by Eoin Bambury and Moshe Zilversmit, is a medical technology company based in Galway, Ireland. The company focuses on developing innovative solutions for the treatment of perianal fistulas, which are small tunnels that form between the bowel and skin near the anus. Signum Surgical has created a bio-absorbable implant that is used post-surgery to securely close the fistula tract, facilitating a faster healing process and reducing the risk of reinfection. This technology aims to provide an effective long-term treatment option for patients suffering from colorectal conditions.

Neurovalens Limited specializes in the development of non-invasive neurostimulation medical devices aimed at addressing global health challenges such as obesity. Founded in 2013 and headquartered in Ballymena, United Kingdom, the company offers products like Stimu Slim and Modius, which are electronic headsets designed to influence brain activity and support weight management. Neurovalens employs advanced technologies to activate specific brain regions, enabling adjustments in autonomic function and neuro-metabolic processes. The company has received funding from Invest NI as part of the European Union’s Investment for Growth and Jobs Programme to support its research and development initiatives, enhancing its competitiveness in the field of neuroscience and bioscience.

Ogletree Deakins is a labor and employment law firm representing management in all types of employment. It represents employers of all sizes and across many industries, from small businesses to Fortune 500 companies.

Konvi is a European crowdfunding platform that facilitates partial ownership of high-yielding luxury assets. The platform allows users to invest in rare and valuable goods, offering greater potential for value appreciation compared to traditional asset classes. By enabling portfolio diversification through access to these exclusive assets, Konvi connects investors with industry experts and luxury funds globally. This approach provides a unique opportunity for individuals to gain exposure to lucrative investment options within the luxury market.

Globus is an AI-powered platform that enhances the staffing and recruitment industry by streamlining and automating various processes. Launched in 2017, it focuses on empowering recruiters and candidates through a sophisticated Software as a Service (SaaS) solution. The platform specializes in engaging and activating existing candidates, efficiently managing incoming job requests, and placing candidates in suitable positions. Additionally, Globus provides actionable business insights that help clients maximize their opportunities and better utilize their talent pools. This innovative approach is aimed at redefining the recruitment landscape, enabling recruiters to place candidates more effectively and rapidly.

Gratsi is a developer of a contactless payment platform aimed at facilitating safe and secure exchanges of gratuity and tips. The platform eliminates the need for cash transactions by offering fully encrypted digital payment solutions. This allows customers in the hospitality and food industries to pay tips and gratuities electronically, enhancing convenience and security for both patrons and service workers.

The Centre for Advanced Sustainable Energy (CASE) is an industry-led sustainable energy research centre. Through the Invest Northern Ireland Competence Centre programme they fund collaborative Research & Development (R&D) in sustainable energy. They bridge the gap between industry research needs and academic research offerings.

Armstrong Medical is a UK-based manufacturer specializing in high-quality, innovative products for use in anaesthesia, respiratory care, and critical care. The company produces a range of respiratory consumables designed to support perioperative and neonatal care. Its products are particularly beneficial for patients experiencing lung injuries, including those resulting from bomb blasts, allowing healthcare providers to effectively utilize these disposable items in critical care settings. Armstrong Medical is dedicated to enhancing patient outcomes through its advanced medical solutions.

We Are Paradoxx is a haircare brand committed to environmental and social responsibility, offering a range of products that are 90% plastic-free and entirely free from toxins, irritants, and synthetic fragrances. The brand focuses on creating ethical and organic haircare solutions through the use of green chemistry, ensuring that all products are vegan and environmentally friendly. With a mission to make sustainable beauty accessible to everyone, We Are Paradoxx offers multi-tasking products designed to meet diverse individual needs while promoting an eco-conscious lifestyle.

We Are Paradoxx is a haircare brand committed to environmental and social responsibility, offering a range of products that are 90% plastic-free and entirely free from toxins, irritants, and synthetic fragrances. The brand focuses on creating ethical and organic haircare solutions through the use of green chemistry, ensuring that all products are vegan and environmentally friendly. With a mission to make sustainable beauty accessible to everyone, We Are Paradoxx offers multi-tasking products designed to meet diverse individual needs while promoting an eco-conscious lifestyle.

Established in 1986 as a joint venture between Fujitsu and Queen’s University Belfast, Kainos has become an international company with offices across the UK, Europe and the USA. And they continue to grow rapidly and fluidly. Throughout, and beyond their industry expertise, their success has been driven by consistently delivering for their customers. They do that by being accessible, collaborative and creative, and by hiring and investing in the best talent. They have always hired the best people they can find, given them challenging work they can cut their teeth on, and driven their development.

SiSaf Ltd. is a biopharmaceutical company that specializes in drug delivery and RNA therapeutics, utilizing its proprietary Bio-Courier technology, which combines organic materials with bioabsorbable silicon to enhance the delivery of RNA. The company's portfolio includes silicon stabilized hybrid lipid nanoparticles designed to improve the stability and efficiency of RNA transfection, addressing the limitations of existing delivery methods. SiSaf aims to develop therapeutics for rare genetic disorders, leveraging its patented technology that allows for controlled drug loading, targeting, and release, while minimizing adverse immune responses. Founded in 2006 and headquartered in Guildford, UK, the company also offers formulation services and licenses its technology to clients across various sectors, including pharmaceuticals and cosmetics. SiSaf has established strategic collaborations and partnerships to further advance its research and development efforts.

Fusion Antibodies plc is a contract research organization based in Belfast, United Kingdom, specializing in the research, development, and manufacture of recombinant proteins and antibodies, particularly for cancer and infectious diseases. The company provides a comprehensive suite of services, including monoclonal antibody discovery and development, antibody engineering, humanization, affinity maturation, and antibody reformatting. Additionally, its offerings encompass antibody sequencing, custom expression and purification of recombinant proteins, transient protein expression, and cell line development. Fusion Antibodies operates on a fee-for-service basis, tailoring its services to meet the specific needs of pharmaceuticals, biotechnology, and diagnostic companies. Established in 2000, the company has built strong partnerships globally, enhancing its ability to deliver high-quality solutions. Its expertise in producing fully humanized monoclonal antibodies is critical for advancing drug development to clinical stages.

BrainWaveBank, established in 2015, is a UK-based brain health research company. It specializes in developing data-centric solutions to track and understand cognitive health. The company's flagship product, also named BrainWaveBank, is a wearable EEG headset that measures brain activity while users engage in mobile games, enabling daily tracking of cognitive health at home. This data is securely stored and analyzed, creating neurocognitive profiles for individuals and populations, and aiding clinical professionals in advancing brain health research and treatments. The company has offices in Belfast, Northern Ireland, and Dublin, Ireland.

ProtectBox operates a cybersecurity comparison marketplace aimed at making cybersecurity accessible to small and medium businesses. Utilizing a proprietary decision-making AI, the platform assesses users' security risk positions and provides tailored bundles of solutions to enhance their security. Users can input their specific cybersecurity needs, and the algorithm generates customized product recommendations. ProtectBox emphasizes sustainability by incorporating ratings and reviews that help users mitigate the carbon impact of their purchases. Additionally, the platform features intelligent chatbots powered by advanced AI, enabling users to interact in various languages and formats, thus enhancing accessibility. Through its innovative approach, ProtectBox aims to make the process of purchasing cybersecurity solutions smarter, greener, and safer for its users.

Ampliphae Ltd, established in 2015 and headquartered in Belfast, UK, specializes in cloud management solutions. It offers a suite of services including cloud application discovery, real-time trend reporting, proactive cloud governance, data privacy compliance, and cloud control. The company's platform uses artificial intelligence and machine learning to identify and mitigate risks associated with the use of Software as a Service (SaaS) applications within organizations. It also provides a database of SaaS applications and manages Bring Your Own Device (BYOD) cloud risks.

SiSaf Ltd. is a biopharmaceutical company that specializes in drug delivery and RNA therapeutics, utilizing its proprietary Bio-Courier technology, which combines organic materials with bioabsorbable silicon to enhance the delivery of RNA. The company's portfolio includes silicon stabilized hybrid lipid nanoparticles designed to improve the stability and efficiency of RNA transfection, addressing the limitations of existing delivery methods. SiSaf aims to develop therapeutics for rare genetic disorders, leveraging its patented technology that allows for controlled drug loading, targeting, and release, while minimizing adverse immune responses. Founded in 2006 and headquartered in Guildford, UK, the company also offers formulation services and licenses its technology to clients across various sectors, including pharmaceuticals and cosmetics. SiSaf has established strategic collaborations and partnerships to further advance its research and development efforts.

Revel Systems, Inc. is a manufacturer and distributor of cloud-based point of sale (POS) and business management solutions. Founded in 2010 and headquartered in Atlanta, Georgia, with additional offices in locations such as San Francisco, Lithuania, Singapore, Australia, and London, the company provides a comprehensive platform that integrates POS software with essential management tools. Its offerings include Revel Essential for small chains and merchants, and Revel Enterprise, designed for larger chains and global enterprises. The platform features capabilities such as inventory management, employee management, integrated payroll, and customer relationship management, all accessible through iOS-based technology on iPads. Revel Systems serves a diverse range of industries, including restaurants, retail, grocery, and service sectors, enabling clients to enhance their operations, improve customer experience, and streamline business processes.

SiSaf Ltd. is a biopharmaceutical company that specializes in drug delivery and RNA therapeutics, utilizing its proprietary Bio-Courier technology, which combines organic materials with bioabsorbable silicon to enhance the delivery of RNA. The company's portfolio includes silicon stabilized hybrid lipid nanoparticles designed to improve the stability and efficiency of RNA transfection, addressing the limitations of existing delivery methods. SiSaf aims to develop therapeutics for rare genetic disorders, leveraging its patented technology that allows for controlled drug loading, targeting, and release, while minimizing adverse immune responses. Founded in 2006 and headquartered in Guildford, UK, the company also offers formulation services and licenses its technology to clients across various sectors, including pharmaceuticals and cosmetics. SiSaf has established strategic collaborations and partnerships to further advance its research and development efforts.

Taggled is an innovative online video commerce platform that allows both personal and business users to create interactive and shoppable videos. The platform provides a user-friendly drag-and-drop interface, enabling video creators to easily add clickable tags for products, people, places, and music within their videos. Taggled's unique solution has demonstrated impressive video view conversion rates ranging from 1% to 5%. As the only Twitter-approved provider of shoppable online videos, Taggled enhances the social shopping experience for a diverse range of users, including video bloggers, performance marketing companies, brands, and retailers.

FD Technologies is a prominent provider of data-driven products and consulting services, catering primarily to major financial, technology, and energy institutions. The company is best known for developing kdb+, a leading database technology that addresses complex data management and analytics challenges. Established in 1996, FD Technologies specializes in delivering mission-critical data and trading systems that support front, middle, and back-office operations, particularly for financial institutions engaged in high-volume trading across various asset classes such as equities, fixed income, and foreign exchange. In addition to its core focus on capital markets, the company extends its expertise to other sectors, including telecoms, digital marketing, pharmaceuticals, and utilities. With a strong presence in the Americas and additional operations in the UK, EMEA, and Asia Pacific, FD Technologies combines deep domain knowledge with technical proficiency in leading financial services systems to help clients navigate the complexities of an increasingly regulated market.

Intune Networks specializes in advanced optical switching technology, enabling telecommunications operators to build more efficient and simpler networks. The company has developed a unique optical Ethernet switch fabric that facilitates real-time packet switching over long distances, utilizing tuneable lasers in accordance with the emerging Optical Burst Switching (OBS) standard. This innovative approach significantly reduces network complexity by minimizing the number of components needed and allows for instantaneous bandwidth allocation at any point in the network. Additionally, Intune's distributed switching system empowers carriers to virtualize connectivity within their networks, transforming mobile transport networks into more flexible and streamlined infrastructures.

SiSaf Ltd. is a biopharmaceutical company that specializes in drug delivery and RNA therapeutics, utilizing its proprietary Bio-Courier technology, which combines organic materials with bioabsorbable silicon to enhance the delivery of RNA. The company's portfolio includes silicon stabilized hybrid lipid nanoparticles designed to improve the stability and efficiency of RNA transfection, addressing the limitations of existing delivery methods. SiSaf aims to develop therapeutics for rare genetic disorders, leveraging its patented technology that allows for controlled drug loading, targeting, and release, while minimizing adverse immune responses. Founded in 2006 and headquartered in Guildford, UK, the company also offers formulation services and licenses its technology to clients across various sectors, including pharmaceuticals and cosmetics. SiSaf has established strategic collaborations and partnerships to further advance its research and development efforts.

Fusion Antibodies plc is a contract research organization based in Belfast, United Kingdom, specializing in the research, development, and manufacture of recombinant proteins and antibodies, particularly for cancer and infectious diseases. The company provides a comprehensive suite of services, including monoclonal antibody discovery and development, antibody engineering, humanization, affinity maturation, and antibody reformatting. Additionally, its offerings encompass antibody sequencing, custom expression and purification of recombinant proteins, transient protein expression, and cell line development. Fusion Antibodies operates on a fee-for-service basis, tailoring its services to meet the specific needs of pharmaceuticals, biotechnology, and diagnostic companies. Established in 2000, the company has built strong partnerships globally, enhancing its ability to deliver high-quality solutions. Its expertise in producing fully humanized monoclonal antibodies is critical for advancing drug development to clinical stages.

Axis Three specializes in developing advanced 3D surgical simulation tools specifically for the cosmetic surgery market. The company has established itself as a leader in this field by offering innovative technology that allows patients to visualize the anticipated outcome of their procedures using realistic three-dimensional models based on their own bodies. Partnering with Siemens, Axis Three has created cutting-edge software that employs physics-driven tissue typing, setting a new standard for predictive surgical simulation. This technology not only enhances the patient experience by providing clearer expectations but also aids surgeons in planning and executing cosmetic procedures with greater precision.

Avalon is a developer, manufacturer and seller of scientific analytical instrumentation based on Raman spectroscopy techniques.

Gendel has developed a unique, proprietary platform technology for the localised delivery of biological molecules to target sites within the body. Biopharmaceuticals may be loaded into the body's own natural carrier system by a physical process and released at the target site in response to the application of non-invasive, low intensity ultrasound. Gendel's technology may be employed for the delivery of a range of biological payloads including antibodies, enzymes, peptides, olionucleotides and DNA as well as carrier peptides and gene therapy vectors.

Aepona Limited is a technology company headquartered in Belfast, United Kingdom, that specializes in providing a platform for business transformation tailored for telecommunications operators and enterprises. Founded in 1995, Aepona enables organizations to leverage their data, connected devices, and infrastructure by creating and monetizing services through managed APIs. Its offerings include an API monetization platform designed for communications service providers, a service creation and orchestration solution that incorporates API management, and a payments and settlement engine that facilitates the implementation of diverse business models. Aepona serves a global customer base across Europe, North America, and Southeast Asia, with additional locations in Bristol, United Kingdom; Colombo, Sri Lanka; and Leixlip, Ireland. The company operates as a subsidiary of Persistent Systems, Inc. as of October 2015.

Lagan Technologies Ltd. specializes in providing enterprise case management solutions tailored for government agencies, primarily in North America and Europe. The company offers a range of products, including an integrated case management system for governmental organizations, a performance solution for 311 call centers, and specialized systems for human services and motor vehicle management. Lagan Technologies also delivers a variety of services, such as project management, consultancy, installation, testing, integration, education and training, and ongoing support and maintenance. Founded in 1994 and headquartered in Belfast, the company has additional offices in London, Chicago, and Washington, D.C., serving advocates and councils both in the United Kingdom and internationally.

Aepona Limited is a technology company headquartered in Belfast, United Kingdom, that specializes in providing a platform for business transformation tailored for telecommunications operators and enterprises. Founded in 1995, Aepona enables organizations to leverage their data, connected devices, and infrastructure by creating and monetizing services through managed APIs. Its offerings include an API monetization platform designed for communications service providers, a service creation and orchestration solution that incorporates API management, and a payments and settlement engine that facilitates the implementation of diverse business models. Aepona serves a global customer base across Europe, North America, and Southeast Asia, with additional locations in Bristol, United Kingdom; Colombo, Sri Lanka; and Leixlip, Ireland. The company operates as a subsidiary of Persistent Systems, Inc. as of October 2015.